Charleston Hematology Oncology Associates PA
West Ashley
Charleston, SC
Accepting patients
SUCCESSOR-2
A Phase 3, Two-stage, Randomized, Multicenter, Open-label Study Comparing CC-92480 (BMS-986348), Carfilzomib, and Dexamethasone (480Kd) Versus Carfilzomib and Dexamethasone (Kd) in Participants with Relapsed or Refractory Multiple Myeloma (RRMM)
- CELMoD
- Randomization
- Phase 3